Australia markets closed

Abeona Therapeutics Inc. (ABEO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
4.5800+0.0600 (+1.33%)
At close: 04:00PM EDT
4.5500 -0.03 (-0.66%)
After hours: 05:03PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 187.20M
Enterprise value 148.02M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)31.32
Price/book (mrq)3.64
Enterprise value/revenue 42.29
Enterprise value/EBITDA -0.58

Trading information

Stock price history

Beta (5Y monthly) 1.51
52-week change 3-3.58%
S&P500 52-week change 326.24%
52-week high 39.0100
52-week low 32.8300
50-day moving average 34.7918
200-day moving average 35.1774

Share statistics

Avg vol (3-month) 3735.22k
Avg vol (10-day) 3548.95k
Shares outstanding 540.96M
Implied shares outstanding 641.19M
Float 830.53M
% held by insiders 13.22%
% held by institutions 155.73%
Shares short (15 May 2024) 43.02M
Short ratio (15 May 2024) 42.34
Short % of float (15 May 2024) 47.58%
Short % of shares outstanding (15 May 2024) 47.33%
Shares short (prior month 15 Apr 2024) 42.06M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:25
Last split date 305 July 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,442.63%

Management effectiveness

Return on assets (ttm)-49.24%
Return on equity (ttm)-1,555.11%

Income statement

Revenue (ttm)3.5M
Revenue per share (ttm)0.15
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -48.37M
Net income avi to common (ttm)-76.66M
Diluted EPS (ttm)-3.1500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)62.34M
Total cash per share (mrq)1.51
Total debt (mrq)23.17M
Total debt/equity (mrq)N/A
Current ratio (mrq)5.61
Book value per share (mrq)-0.32

Cash flow statement

Operating cash flow (ttm)-39.8M
Levered free cash flow (ttm)-21.28M